Arrhythmia induced cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Research

Background:

• Arrhythmia induced cardiomyopathies (AIC) encompass conditions like tachycardia and ectopy-induced cardiomyopathy.
• Atrial fibrillation (AF) and heart failure (HF) are prevalent, often co-occurring, and mutually worsening conditions.
• AF-mediated cardiomyopathy is a significant clinical challenge within AIC.

Purpose of the Study:

• To provide a comprehensive overview of AIC.
• To review current evidence for the treatment and management of AIC.
• To focus on AF-mediated cardiomyopathy and propose strategies for recognition, screening, and management.

Main Methods:

• Literature review of current understanding and evidence.
• Analysis of the interplay between AF and HF.
• Synthesis of diagnostic and therapeutic approaches for AIC.

Main Results:

• AIC represents a spectrum of heart muscle dysfunction driven by arrhythmias.
• AF is a common and critical driver of cardiomyopathy, leading to heart failure.
• Effective management requires integrated approaches for both arrhythmia and heart failure.

Conclusions:

• Early recognition and screening are crucial for identifying patients at risk of AIC.
• Management strategies should target both the underlying arrhythmia and the resulting cardiomyopathy.
• Further research is needed to optimize treatment protocols for AIC, particularly AF-mediated forms.